Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

March 01, 1996; Volume 49,Issue 3
  • You have access
    Coexpression with potassium channel subunits used to clone the Y2 receptor for neuropeptide Y.
    J M Rimland, E P Seward, Y Humbert, E Ratti, D G Trist and R A North
    Molecular Pharmacology March 1996, 49 (3) 387-390;
  • You have access
    The aryl-hydrocarbon receptor, but not the aryl-hydrocarbon receptor nuclear translocator protein, is rapidly depleted in hepatic and nonhepatic culture cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    R S Pollenz
    Molecular Pharmacology March 1996, 49 (3) 391-398;
  • You have access
    Epidermal growth factor-mediated inhibition of neurotransmitter glutamate release from rat forebrain synaptosomes.
    A Barrie, E Chieregatti, M Miloso, F Benfenati and F Valtorta
    Molecular Pharmacology March 1996, 49 (3) 399-403;
  • You have access
    Role of Cu/Zn-superoxide dismutase in xenobiotic activation. I. Chemical reactions involved in the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
    Y Li, P Kuppusamy, J L Zweier and M A Trush
    Molecular Pharmacology March 1996, 49 (3) 404-411;
  • You have access
    Role of Cu/Zn-superoxide dismutase in xenobiotic activation. II. Biological effects resulting from the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
    Y Li, P Kuppusamy, J L Zweir and M A Trush
    Molecular Pharmacology March 1996, 49 (3) 412-421;
  • You have access
    Changes in the carboxyl-terminal domain of metabotropic glutamate receptor 1 by alternative splicing generate receptors with differing agonist-independent activity.
    L Prézeau, J Gomeza, S Ahern, S Mary, T Galvez, J Bockaert and J P Pin
    Molecular Pharmacology March 1996, 49 (3) 422-429;
  • You have access
    Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties.
    E A Ercikan-Abali, M C Waltham, A P Dicker, B I Schweitzer, H Gritsman, D Banerjee and J R Bertino
    Molecular Pharmacology March 1996, 49 (3) 430-437;
  • You have access
    Mechanisms of desensitization and resensitization of G protein-coupled neurokinin1 and neurokinin2 receptors.
    A M Garland, E F Grady, M Lovett, S R Vigna, M M Frucht, J E Krause and N W Bunnett
    Molecular Pharmacology March 1996, 49 (3) 438-446;
  • You have access
    Endothelin-1-induced mitogenic responses of Chinese hamster ovary cells expressing human endothelinA: the role of a wortmannin-sensitive signaling pathway.
    F Sugawara, H Ninomiya, Y Okamoto, S Miwa, O Mazda, Y Katsura and T Masaki
    Molecular Pharmacology March 1996, 49 (3) 447-457;
  • You have access
    Expression and zonal distribution of CYP2D16 in the guinea pig adrenal cortex: relationship to xenobiotic metabolism.
    Q Jiang, Y Huang, J M Voigt, B K DeBolt, S Kominami, S Takemori, Y Funae and H D Colby
    Molecular Pharmacology March 1996, 49 (3) 458-464;
  • You have access
    Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1).
    L A Dowd, A J Coyle, J D Rothstein, D B Pritchett and M B Robinson
    Molecular Pharmacology March 1996, 49 (3) 465-473;
  • You have access
    Differences in agonist-independent and -dependent 5-hydroxytryptamine2C receptor-mediated cell division.
    R S Westphal and E Sanders-Bush
    Molecular Pharmacology March 1996, 49 (3) 474-480;
  • You have access
    Activation of 5-hydroxytryptamine4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-hydroxytryptamine-induced steroid secretion.
    V Contesse, C Hamel, H Lefebvre, A Dumuis, H Vaudry and C Delarue
    Molecular Pharmacology March 1996, 49 (3) 481-493;
  • You have access
    Homomeric beta 1 gamma-aminobutyric acid A receptor-ion channels: evaluation of pharmacological and physiological properties.
    B J Krishek, S J Moss and T G Smart
    Molecular Pharmacology March 1996, 49 (3) 494-504;
  • You have access
    Gastrin-releasing peptide receptor signaling resulting in growth inhibition.
    R I Feldman, S Fried, E Mann, J M Wu and M Liang
    Molecular Pharmacology March 1996, 49 (3) 505-514;
  • You have access
    Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral.
    G M Raner, A D Vaz and M J Coon
    Molecular Pharmacology March 1996, 49 (3) 515-522;
  • You have access
    Phenobarbital induction of hepatic CYP2B1 and CYP2B2: pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose.
    A K Agrawal and B H Shapiro
    Molecular Pharmacology March 1996, 49 (3) 523-531;
  • You have access
    Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
    S Mankhetkorn, F Dubru, J Hesschenbrouck, M Fiallo and A Garnier-Suillerot
    Molecular Pharmacology March 1996, 49 (3) 532-539;
  • You have access
    Antagonist pharmacology of kainate- and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring receptors.
    T J Wilding and J E Huettner
    Molecular Pharmacology March 1996, 49 (3) 540-546;
  • You have access
    N-[5-nitro-2-furfurylidene]-3-amino-2-oxazolidinone activation by the human intestinal cell line Caco-2 monitored through noninvasive electron spin resonance spectroscopy.
    L Rossi, I De Angelis, J Z Pedersen, E Marchese, A Stammati, G Rotilio and F Zucco
    Molecular Pharmacology March 1996, 49 (3) 547-555;
  • You have access
    Are 5-hydroxytryptamine7 receptors involved in [3H]5-hydroxytryptamine binding to 5-hydroxytryptamine 1nonA-nonB receptors in rat hypothalamus?
    M Gobbi, L Parotti and T Mennini
    Molecular Pharmacology March 1996, 49 (3) 556-559;
  • You have access
    Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells.
    M Itokawa, M Toru, K Ito, H Tsuga, K Kameyama, T Haga, T Arinami and H Hamaguchi
    Molecular Pharmacology March 1996, 49 (3) 560-566;
  • You have access
    Properties of putative cerebellar gamma-aminobutyric acid A receptor isoforms.
    N C Saxena and R L Macdonald
    Molecular Pharmacology March 1996, 49 (3) 567-579;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 49, Issue 3
1 Mar 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics